Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the Rat-Reference-Cited by-同舟云学术

Characterization of Behavioral and Neurodegenerative Changes Following Partial Lesions of the Nigrostriatal Dopamine System Induced by Intrastriatal 6-Hydroxydopamine in the Rat

Published:1998-08 Issue:2 Volume:152 Page:259-277
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Kirik Deniz,Rosenblad Carl,Björklund Anders

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference46 articles.

1. Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,5,6-tetrahydropterine (MPTP): Seven cases;Ballard;Neurology,1985

2. Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat;Barnéoud;Neuroscience,1995

3. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal injection in rats;Berger;Brain Res. Bull.,1991

4. Brain dopamine and the syndromes of Parkinson and Huntington;Bernheimer;J. Neurol. Sci.,1973

5. Dopamine containing systems in the CNS;Björklund,1984

Cited by 569 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The AAV-α-Synuclein Model of Parkinson’s Disease: An Update;Journal of Parkinson's Disease;2024-09-03

2. Secretome of bone marrow mesenchymal stromal cells cultured in a dynamic system induces neuroprotection and modulates microglial responsiveness in an α-synuclein overexpression rat model;Cytotherapy;2024-07

3. Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease;International Journal of Molecular Sciences;2024-04-14

4. Exploiting spatiotemporal regulation of FZD5 during neural patterning for efficient ventral midbrain specification;Development;2024-03-01

5. Review: Lower urinary tract dysfunction in animal models of Parkinson’s disease (PD): Translational aspects for the treatment of PD patients with overactive bladder;International Review of Neurobiology;2024